Similar articles

• Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.

  Espaldon R, Kirby KA, Fung KZ, Hoffman RM, Powell AA, Freedland SJ, Walter LC. Espaldon R, et al. Urology. 2014 Mar;83(3):599-605. doi: 10.1016/j.urology.2013.10.051. Epub 2014 Jan 16. Urology. 2014. PMID: 24439009 Free PMC article.
• Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.

  Chinea FM, Lyapichev K, Epstein JI, Kwon D, Smith PT, Pollack A, Cote RJ, Kryvenko ON. Chinea FM, et al. Oncotarget. 2017 Mar 28;8(13):20802-20812. doi: 10.18632/oncotarget.14903. Oncotarget. 2017. PMID: 28160549 Free PMC article.
• Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

  Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A. Shavers VL, et al. Med Care. 2004 Mar;42(3):239-50. doi: 10.1097/01.mlr.0000117361.61444.71. Med Care. 2004. PMID: 15076823
• Cardiovascular risk in special populations II: hypertension.

  Liebson PR. Liebson PR. Prev Cardiol. 2009 Fall;12(4):189-97. doi: 10.1111/j.1751-7141.2009.00042.x. Prev Cardiol. 2009. PMID: 19751483 Review. No abstract available.
• The quest for explanations for race/ethnic disparity in rates of use of total joint arthroplasty.

  Hawker GA. Hawker GA. J Rheumatol. 2004 Sep;31(9):1683-5. J Rheumatol. 2004. PMID: 15338484 Review. No abstract available.